Skip to content

Nicholas Conrad Smith, President and CFO at Alto Neuroscience, sold ANRO on Sep 29, 2026

Data as of Oct 16

▼ SELL$2.9M110,830 shares at $26.58Nicholas Conrad Smith President and CFOANRO Alto Neuroscience, Inc.
Watch ANRO
Traded
Sep 29, 2026
Disclosed
Oct 1, 2026
Filed
2 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Nicholas Conrad Smith, President and CFO at Alto Neuroscience, sold ANRO on Sep 29, 2026TRADEDDISCLOSED
ANROSimilar stocks (XLV — its sector index fund), rebased to ANRO's price on the disclosure day
ANRO since disclosure
−13.3%
after the sale
Similar stocks (XLV) since disclosure
+6.3%
XLV — its sector index fund

Change in closing price from Oct 1, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLNicholas Conrad Smith President and CFOANRO Alto Neuroscience, Inc.$23.8Kdisclosed Oct 1 · filed 1 day after the trade
  2. ▼ SELLNicholas Conrad Smith President and CFOANRO Alto Neuroscience, Inc.$597Kdisclosed Oct 1 · filed 1 day after the trade

See every trade on ANRO →